SMR Stock Slides As Fraud Probe Follows UBS Downgrade
NuScale Power Corporation (NYSE: SMR) shares fell 7.29% on October 12, 2026, amid concerns over project delays, a UBS downgrade, and a fraud probe. UBS cut its price target to $6, citing execution risks and negative free cash flow expectations. SMR reported Q2 2026 revenue of $75,000 and a net loss of $47.54M. Analysts' average price target is $12.37, with a consensus 'Hold' rating.
How this was made

The 30-second read
Why it matters
The combined downgrade and fraud investigation represent a fresh, material catalyst likely to keep selling pressure on SMR for the near term.
Market read
The news is a primary disclosure for SMR, creating immediate sell pressure and potential short‑term trading opportunities.
What to watch
RBC's Hold stance and an average analyst target of $12.37 suggest some upside potential if the legal risk eases.
Background
SMR is a penny‑stock focused on small modular nuclear reactors, previously trading in an $8‑$9 range before recent negative catalyst.
Ticker impact
UBS downgraded SMR to Sell and cut the price target, and Pomerantz LLP launched a securities‑fraud investigation, driving the stock down 7.3% intraday.
likely further downside as investors price in legal risk and reduced earnings outlook
Both the downgrade and the investigation are fresh, material events for a micro‑cap; no prior coverage existed, and the stock already fell sharply on the news.
Market effects
Highlights heightened risk for other small‑modular reactor and niche clean‑energy firms facing execution uncertainty.
Primarily U.S. micro‑cap investors; limited broader market effect.
Minimal global impact beyond niche energy‑tech investors.
Counterpoint
If the fraud probe stalls or is dismissed, the stock could rebound on its strong cash position and lack of debt.
Key entities
- companyNuScale Power Corporation
Issuer of SMR stock, subject of downgrade and fraud probe.
- analyst_firmUBS
Downgraded SMR to Sell and cut price target.
- law_firmPomerantz LLP
Launched securities‑fraud investigation into NuScale.




